US appeals court revives hundreds of private lawsuits linking Tylenol to autism

A US appeals court has overturned a lower court's decision to dismiss hundreds of lawsuits claiming that Tylenol, a popular painkiller, contributed to autism in children. The judges ruled that the lower court improperly excluded key expert testimonies that could bolster the plaintiffs' cases. This decision is significant as it reopens legal avenues for families seeking to link the drug to developmental disorders, despite widespread scientific consensus that there's no proven link between Tylenol and autism. The move could prompt further scrutiny and debate on the court's role in evaluating scientific evidence in litigation.